Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1191-50-0
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of sodium tetradecyl sulfate during breastfeeding. Although sodium tetradecyl sulfate is unlikely to adversely affect the breastfed infant, international guidelines recommend that breastfeeding be withheld for 2 days after sclerotherapy.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Wong M, Parsi K, Myers K, et al. Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023. Phlebology. 2023;38:205–58. [PubMed: 36916540]
Substance Identification
Substance Name
CAS Registry Number
1191-50-0
Drug Class
Breast Feeding
Milk, Human
Sclerosing Solutions
Sclerotherapies
Surface-Active Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.[Phlebology. 2017]Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.Bush R, Bush P. Phlebology. 2017 Aug; 32(7):496-500. Epub 2016 Oct 12.
- Review Sodium Picosulfate.[Drugs and Lactation Database (...]Review Sodium Picosulfate.. Drugs and Lactation Database (LactMed®). 2006
- Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.[Indian J Med Res. 2001]Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.Ravi M, Kate V, Ananthakrishnan N. Indian J Med Res. 2001 Jun; 113:228-33.
- Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.[Gastrointest Endosc. 1998]Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.Sung JJ, Yeo W, Suen R, Lee YT, Chung SC, Chan FK, Johnson PJ. Gastrointest Endosc. 1998 Mar; 47(3):235-9.
- Review Iothalamate.[Drugs and Lactation Database (...]Review Iothalamate.. Drugs and Lactation Database (LactMed®). 2006
- Sodium Tetradecyl Sulfate - Drugs and Lactation Database (LactMed®)Sodium Tetradecyl Sulfate - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...